Prange Karen
SEC Form 4 insider trading activity
Prange Karen has filed 6 SEC Form 4 filings (6 transaction rows) across 3 companies, including ATRC, OM, EMBC, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Prange Karen is listed as Director at AtriCure, Inc. Inside the rolling window, Prange Karen reported no open-market purchases and 2 open-market sales totaling $224K in ATRC. The largest disclosed transaction in the window is a sale of 3,564 ATRC shares on Aug 5, 2026, worth $138K.
Companies traded
Other insiders at ATRC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$224K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Prange Karen made?
Prange Karen has filed 6 SEC Form 4 filings (6 transaction rows) across 3 companies, including ATRC, OM, EMBC since 2026.
Which companies does Prange Karen trade?
Prange Karen has filed SEC Form 4 disclosures for 3 companies, including ATRC, OM, EMBC.
When was Prange Karen's most recent SEC Form 4 filing?
Prange Karen's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Prange Karen's total buy and sell value in the current window?
Inside the rolling retention window, Prange Karen bought $0 and sold $224K based on SEC Form 4 filings.
What was Prange Karen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,564 ATRC shares on 2026-08-05, worth $138K, per SEC Form 4 filings.